Free Trial
NASDAQ:TNFA

TNF Pharmaceuticals (TNFA) Stock Price, News & Analysis

TNF Pharmaceuticals logo
$0.17 +0.01 (+7.06%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$0.17 -0.01 (-4.24%)
As of 05/23/2025 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About TNF Pharmaceuticals Stock (NASDAQ:TNFA)

Key Stats

Today's Range
$0.16
$0.18
50-Day Range
$0.15
$0.44
52-Week Range
$0.15
$2.16
Volume
1.08 million shs
Average Volume
763,870 shs
Market Capitalization
$1.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

TNF Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company. It focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms. Its MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. The MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases. The company's second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. The Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve the growing CBD market, which includes FDA approved drugs and CBD products not regulated as drugs. TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July 2024. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

Receive TNFA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TNF Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

TNFA Stock News Headlines

Financial Contrast: TNF Pharmaceuticals (TNFA) and Its Peers
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Contrasting TNF Pharmaceuticals (TNFA) & Its Peers
Reviewing TNF Pharmaceuticals (TNFA) and Its Competitors
See More Headlines

TNFA Stock Analysis - Frequently Asked Questions

TNF Pharmaceuticals' stock was trading at $1.15 at the beginning of 2025. Since then, TNFA stock has decreased by 84.8% and is now trading at $0.1744.
View the best growth stocks for 2025 here
.

TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) issued its earnings results on Thursday, May, 15th. The company reported ($0.36) earnings per share (EPS) for the quarter.

Shares of TNFA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that TNF Pharmaceuticals investors own include Amprius Technologies (AMPX), Archrock (AROC), Axon Enterprise (AXON), PACCAR (PCAR), Bitfarms (BITF), Bitfarms (BFARF) and BigBear.ai (BBAI).

Company Calendar

Last Earnings
5/15/2025
Today
5/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic substances
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TNFA
Employees
6
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-4,000,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$7.21 per share
Price / Book
0.02

Miscellaneous

Free Float
2,722,000
Market Cap
$1.77 million
Optionable
N/A
Beta
2.13
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:TNFA) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners